Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 21 04:00PM ET
3.15
Dollar change
-0.15
Percentage change
-4.55
%
Index- P/E- EPS (ttm)-5.16 Insider Own0.82% Shs Outstand1.36M Perf Week-2.48%
Market Cap4.30M Forward P/E- EPS next Y-2.19 Insider Trans14.29% Shs Float1.35M Perf Month-28.33%
Income-7.04M PEG- EPS next Q-0.98 Inst Own10.74% Short Float0.92% Perf Quarter-46.61%
Sales5.31M P/S0.81 EPS this Y11.04% Inst Trans152.90% Short Ratio1.02 Perf Half Y8.62%
Book/sh4.56 P/B0.69 EPS next Y22.34% ROA-34.87% Short Interest0.01M Perf Year27.53%
Cash/sh3.11 P/C1.01 EPS next 5Y- ROE-60.76% 52W Range1.85 - 10.31 Perf YTD-46.79%
Dividend Est.- P/FCF- EPS past 5Y50.91% ROI-113.10% 52W High-69.45% Beta0.75
Dividend TTM- Quick Ratio3.25 Sales past 5Y109.51% Gross Margin37.67% 52W Low70.16% ATR (14)0.23
Dividend Ex-Date- Current Ratio3.61 EPS Y/Y TTM64.05% Oper. Margin-170.96% RSI (14)29.67 Volatility5.46% 5.70%
Employees21 Debt/Eq0.02 Sales Y/Y TTM-6.20% Profit Margin-132.44% Recom1.00 Target Price12.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-34.26% Payout- Rel Volume0.25 Prev Close3.30
Sales Surprise5.74% EPS Surprise-234.83% Sales Q/Q3.93% EarningsMar 20 AMC Avg Volume12.12K Price3.15
SMA20-10.32% SMA50-27.16% SMA200-15.13% Trades Volume3,067 Change-4.55%
Date Action Analyst Rating Change Price Target Change
Aug-17-20Reiterated H.C. Wainwright Buy $14 → $12
May-12-17Downgrade Piper Jaffray Overweight → Neutral
Jun-09-15Initiated Piper Jaffray Overweight $10
Jun-09-15Initiated Credit Suisse Outperform $14
Mar-21-25 12:06PM
07:12AM
03:05AM
Mar-20-25 07:37PM
07:37PM
04:05PM Loading…
04:05PM
10:00AM
Mar-19-25 05:35PM
Mar-06-25 08:02AM
Feb-07-25 07:25AM
Dec-07-24 06:42AM
Dec-05-24 08:02AM
Nov-13-24 08:18AM
02:17AM
Nov-12-24 07:20PM
06:25PM Loading…
06:25PM
04:05PM
Nov-07-24 07:13AM
Oct-29-24 08:30AM
Aug-14-24 11:02AM
Aug-13-24 05:15PM
04:13PM
04:05PM
Jul-30-24 01:30PM
Jul-17-24 12:00PM
Jul-10-24 12:53PM
Jul-09-24 08:02AM
May-17-24 12:28PM
08:02AM
06:31AM
12:12PM Loading…
May-16-24 12:12PM
08:02AM
May-14-24 08:02AM
May-11-24 09:40AM
May-10-24 08:35AM
May-09-24 08:57PM
06:20PM
05:17PM
04:05PM
May-02-24 10:01AM
Apr-25-24 08:02AM
Apr-01-24 11:21AM
10:44AM
Mar-29-24 09:51AM
Mar-28-24 09:53PM
07:25PM
06:32PM
04:05PM
Mar-14-24 08:02AM
Feb-20-24 08:02AM
Nov-11-23 12:02PM
Nov-10-23 10:26AM
Nov-09-23 04:47PM
04:05PM
Oct-26-23 08:02AM
Oct-25-23 06:51AM
Oct-03-23 08:02AM
Sep-05-23 08:02AM
Sep-01-23 09:43AM
Aug-11-23 06:58AM
Aug-10-23 06:05PM
04:53PM
04:05PM
Aug-09-23 06:05PM
Aug-08-23 06:05PM
Jul-27-23 10:19AM
Jul-21-23 10:04AM
Jul-20-23 08:02AM
Jul-17-23 08:02AM
Jun-14-23 10:04AM
May-12-23 05:41AM
May-11-23 04:05PM
May-08-23 08:01AM
Apr-28-23 08:02AM
Apr-09-23 07:33PM
Mar-30-23 04:38PM
04:05PM
Mar-23-23 06:54AM
Mar-22-23 10:22AM
08:02AM
Mar-02-23 07:00PM
Mar-01-23 01:54PM
Jan-19-23 09:07AM
Jan-18-23 08:00AM
Dec-28-22 08:10AM
Dec-08-22 08:00AM
Nov-30-22 04:30PM
Nov-13-22 07:55AM
Nov-10-22 07:05PM
04:05PM
Oct-27-22 08:00AM
Sep-29-22 01:38PM
Aug-31-22 08:00AM
Aug-16-22 05:00PM
Aug-12-22 07:10PM
Aug-11-22 04:05PM
Jul-28-22 08:00AM
Jun-01-22 05:52PM
09:00AM
May-12-22 04:05PM
Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kawakami MarkChief Financial OfficerFeb 03 '25Buy2.497001,7432,681Feb 05 07:34 PM
Schaefer Thomas J.Chief Executive OfficerFeb 03 '25Buy2.497001,7432,819Feb 05 07:24 PM
Kawakami MarkChief Financial OfficerAug 01 '24Buy2.067001,4421,981Aug 20 08:11 PM
Schaefer Thomas J.Chief Executive OfficerAug 01 '24Buy2.067001,4422,119Aug 20 08:05 PM